Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

30.68
Delayed Data
As of Sep 04
 -0.33 / -1.06%
Today’s Change
29.06
Today|||52-Week Range
40.05
-9.74%
Year-to-Date
No recent news for Grifols SA.

Today’s Trading

Previous close31.01
Today’s open30.83
Day’s range30.48 - 31.01
Volume610,832
Average volume (3 months)378,788
Market cap$3.9B
Dividend yield2.12%
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)+34.74%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.75%
Revenue growth (last year)+21.57%
P/E ratio--
Price/Sales2.63
Price/Book3.26

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...+0.33+0.84%
NBIXNeurocrine Bioscienc...+0.46+0.96%
AKRXAkorn Inc-0.08-0.21%
ICPTIntercept Pharmaceut...-1.85-0.99%
Data as of 3:59pm ET, 09/04/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)$0.46
Annual revenue (last year)$4.4B
Annual profit (last year)$621.4M
Net profit margin14.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Víctor Grifols Roura
Chief Financial Officer &
Vice President
Alfredo Arroyo Guerra
Corporate headquarters
Barcelona, Catalonia

Forecasts

Partner Offers